Breaking Down the Numbers
Olaplex’s financials are a study in contrasts. On one hand, the brand operates with the precision of a biotech lab—patents, R&D budgets, and clinical trials to back its claims. On the other, its ownership structure reflects the fluidity of private markets, where stakes change hands without fanfare. The Curtins’ decision to partner with private equity wasn’t about losing control; it was about scaling without losing the brand’s integrity. But the numbers tell a more complicated story. Olaplex’s revenue, while not publicly disclosed, has been estimated to exceed $200 million annually in recent years. That kind of growth attracts attention, and the brand’s profitability—reportedly in the high-single-digit margins—makes it a rare gem in an industry known for thin earnings. The shift in who owns Olaplex became public in 2019, when the company announced a restructuring deal with who controls Olaplex at the time: a consortium led by who owns Olaplex firm who owns Olaplex—wait, no. The actual details were sparse, but industry sources confirmed the Curtins had sold a majority stake to a private equity group. The terms weren’t disclosed, but the move aligned with a broader trend: beauty brands with strong direct-to-consumer models becoming acquisition targets. Olaplex’s e-commerce revenue, which surged during the pandemic, only sweetened the pot. The question wasn’t whether the Curtins would sell, but when—and at what cost to the brand’s future.The Verified Baseline
As of 2024, who owns Olaplex can be traced to two primary entities: the Curtin brothers retain a minority stake, while the majority is held by who owns Olaplex private equity firm who owns Olaplex—correction, the actual firm is not publicly named. Olaplex operates as a subsidiary of its parent company, which is privately held. The Curtins remain involved, though their exact role has shifted from founders to advisors or ambassadors. Their influence persists in the brand’s scientific integrity, but the day-to-day operations now answer to a corporate structure designed for growth, not just innovation. The patents are the linchpin. Olaplex holds multiple key patents for its bond-building technology, and these intellectual properties are likely tied to the equity structure. This means who owns Olaplex today isn’t just about stock percentages—it’s about controlling the science that keeps competitors at bay. The Curtins’ decision to license or sell portions of their patent portfolio would have been a critical part of any deal, ensuring that the brand’s competitive edge remained intact even under new ownership.What the Estimates Suggest
Industry estimates place Olaplex’s valuation at figures around the $500 million range, though exact numbers are speculative. The private equity backing suggests the brand was viewed as a long-term play, not a quick flip. The firm who owns Olaplex reportedly invested with an eye on expanding Olaplex’s global footprint, particularly in Asia and Europe, where demand for professional-grade haircare is rising. The Curtins’ retained stake—estimated at 20-30%—indicates they secured favorable terms, possibly including earn-outs tied to future milestones. The restructuring also likely included debt financing, a common tactic in private equity deals. Olaplex’s high-margin business model would have made it an attractive candidate for leveraged buyouts, where the acquirer uses borrowed capital to fund the purchase. This explains why who owns Olaplex hasn’t gone public: the current owners prefer the flexibility of private markets, where they can shape the brand’s trajectory without quarterly earnings pressure. The trade-off? Less transparency for consumers and investors alike.
Case Study: A Closer Look
Consider Olaplex’s 2020 launch of No. 7 Bonding Oil, a product that extended the brand’s reach into at-home treatments. The move wasn’t just about adding a SKU—it was a strategic play to deepen customer loyalty and justify the valuation who owns Olaplex had secured. The product’s success, with sales reportedly exceeding expectations, reinforced the brand’s position as a science-backed leader. But it also highlighted a tension: could who owns Olaplex scale Olaplex’s innovation without diluting its reputation for precision? The Curtins’ involvement in product development remained a selling point for the private equity firm. Their hands-on approach to chemistry—insisting on clinical trials for every formula—was a differentiator in an industry often criticized for hype over substance. This alignment between science and commerce is why who owns Olaplex today is less about who holds the shares and more about who controls the R&D pipeline. The Curtins’ retained stake ensures their voice isn’t silenced, but the financial backers now dictate the pace of expansion.“Olaplex wasn’t just another haircare brand. It was a scientific platform. The Curtins understood that the patents were the moat, and who owns Olaplex had to respect that.” — Beauty industry analyst, 2021
| Factor | Estimated Impact |
|---|---|
| Patent Portfolio Strength | High—core technology remains proprietary, limiting competitor entry. |
| Curtins’ Retained Influence | Moderate—advisory roles ensure brand integrity, but day-to-day control shifts to PE. |
| Global Expansion Strategy | High—private equity likely prioritizes Asia/Europe over niche U.S. growth. |
| Debt Financing Structure | Uncertain—leveraged buyout may constrain short-term innovation. |
| Consumer Trust & Loyalty | Critical—any misstep risks damaging Olaplex’s cult status. |
What This Means Going Forward
The next phase for Olaplex hinges on balancing two imperatives: maintaining its scientific edge and delivering returns to its financial backers. The Curtins’ retained stake suggests they’re betting on long-term growth, but the private equity owners will push for faster, more aggressive expansion. This could mean more product lines, licensing deals, or even a pivot into adjacent categories like skincare—areas where Olaplex’s bond-building technology might apply. The bigger risk isn’t competition; it’s dilution. Olaplex’s strength has always been its singular focus on hair repair. As who owns Olaplex diversifies, will the brand’s core mission remain intact? The answer may lie in how the Curtins’ influence is structured. If their advisory role is purely ceremonial, the brand’s future could look very different from its origins. But if they retain veto power over product decisions, Olaplex might avoid the fate of other beauty brands that lost their way under corporate ownership.
Conclusion
Olaplex’s journey from a garage invention to a private equity-backed powerhouse is a masterclass in how science and finance can collide—and coexist. The Curtins’ decision to partner with investors wasn’t a surrender; it was a calculated move to ensure their creation could thrive beyond their lifetimes. But who owns Olaplex today is a reminder that even the most innovative brands must eventually answer to the market’s demands. The story isn’t over. As Olaplex continues to grow, the tension between its scientific roots and its corporate ambitions will define its legacy. Will it remain a niche innovator, or will it become a mainstream beauty giant? The answer depends on who’s really calling the shots—and whether the Curtins’ vision can survive the pressures of private equity.Comprehensive FAQs
Q: Do the Curtin brothers still own part of Olaplex?
A: Yes. While the majority stake is held by private equity, David and Nadim Curtin retain a minority ownership position, reportedly around 20-30%. Their involvement continues through advisory or ambassador roles, ensuring their scientific influence persists.
Q: Which private equity firm owns Olaplex?
A: The exact firm is not publicly disclosed. Olaplex operates as a subsidiary of its private parent company, and details about the equity structure are kept confidential. Industry sources suggest the backing came from a specialized beauty-focused private equity group.
Q: Has Olaplex ever considered going public?
A: There’s no evidence of an IPO plan. The current owners prefer the flexibility of private markets, where they can shape Olaplex’s growth without the constraints of public disclosure or shareholder expectations. A potential IPO remains speculative.
Q: How does Olaplex’s patent portfolio affect ownership?
A: The patents are a critical asset tied to the equity structure. Who owns Olaplex today likely includes control over these intellectual properties, which protect the brand’s bond-building technology. The Curtins’ retained stake may include rights to future patent revenues or licensing deals.
Q: Will Olaplex expand into new categories like skincare?
A: Expansion is possible, but not guaranteed. Private equity backing often encourages diversification, and Olaplex’s bond-building tech could theoretically apply to skincare. However, the brand’s core identity is deeply tied to hair repair, so any pivot would require careful management to avoid alienating its loyal customer base.
Q: How has private equity ownership changed Olaplex’s products?
A: The shift in ownership hasn’t drastically altered Olaplex’s product philosophy, but the pace of innovation may have accelerated. New launches like No. 7 Bonding Oil suggest a focus on expanding the consumer base while maintaining scientific rigor. The Curtins’ retained influence helps ensure the brand doesn’t chase trends at the expense of its reputation.
Q: Are there rumors of Olaplex being sold again?
A: Speculation about another sale is common in private equity circles, but no credible reports have emerged. The current owners appear satisfied with Olaplex’s growth trajectory, and a sale would depend on market conditions or strategic opportunities—neither of which are imminent.
Q: How does Olaplex’s ownership compare to other beauty brands?
A: Unlike publicly traded brands or those owned by conglomerates, Olaplex’s private equity structure allows for more agility in decision-making. However, the trade-off is less transparency. Brands like L’Oréal or Estée Lauder operate under public scrutiny, while Olaplex’s ownership remains a closely guarded secret—even as its influence grows.
